Shanghai Bao Pharmaceuticals Co (HKSE:02659) ROCE %: -28.08% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02659 Shanghai Bao Pharmaceuticals Co Ltd HKSE:02659
9 GF Score
Price HK$15.94
! 2 Warning Signs
View Full Analysis

What is Shanghai Bao Pharmaceuticals Co ROCE %?

Shanghai Bao Pharmaceuticals Co HKSE:02659 +0.25% 9 ROCE % is -28.08% as of Dec. 2025. GuruFocus rates HKSE:02659 with a GF Score™ of 9/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Bao Pharmaceuticals Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -28.08%.

Shanghai Bao Pharmaceuticals Co  (HKSE:02659) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Bao Pharmaceuticals Co ROCE % Related Terms

Shanghai Bao Pharmaceuticals Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shanghai Bao Pharmaceuticals Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bao Pharmaceuticals Co ROCE % Chart

Shanghai Bao Pharmaceuticals Co Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
-18.95 -35.73 -25.83

Shanghai Bao Pharmaceuticals Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % 0.00 -39.34 -33.35 -32.21 -28.08
HKSE:02659
9GF Score
Shanghai Bao Pharmaceuticals Co Ltd HKSE:02659
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Bao Pharmaceuticals Co ROCE % Calculation

Shanghai Bao Pharmaceuticals Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-430.1/( ( (1455.522 - 209.51) + (2449.152 - 365.28) )/ 2 )
=-430.1/( (1246.012+2083.872)/ 2 )
=-430.1/1664.942
=-25.83 %

Shanghai Bao Pharmaceuticals Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-461.55/( ( (1517.917 - 314.659) + (2449.152 - 365.28) )/ 2 )
=-461.55/( ( 1203.258 + 2083.872 )/ 2 )
=-461.55/1643.565
=-28.08 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -28.08% mean?
Shanghai Bao Pharmaceuticals Co (HKSE:02659) has a ROCE % of -28.08% as of Dec. 2025.
Is Shanghai Bao Pharmaceuticals Co's ROCE % too high?
Shanghai Bao Pharmaceuticals Co's current ROCE % is -28.08%. Overall, Shanghai Bao Pharmaceuticals Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Bao Pharmaceuticals Co's ROCE % compare to VRTX and REGN?
Shanghai Bao Pharmaceuticals Co's ROCE % of -28.08% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Shanghai Bao Pharmaceuticals Co's current ROCE % is -28.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Bao Pharmaceuticals Co stock overvalued right now?
Shanghai Bao Pharmaceuticals Co (HKSE:02659) has a current ROCE % of -28.08%. The current ROCE % is -28.08%. Shanghai Bao Pharmaceuticals Co's overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shanghai Bao Pharmaceuticals Co (HKSE:02659), the current ROCE % is -28.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Bao Pharmaceuticals Co Business Description

Address No. 28 Luoxin Road, Baoshan District, Shanghai, CHN
Shanghai Bao Pharmaceuticals Co Ltd is a biotechnology company with an approved product and a diverse clinical pipeline, leveraging synthetic biology technology to develop and deliver recombinant biologic drugs in China, targeting conditions with limited treatment options and complex manufacturing challenges. The company has proprietary technology platforms, supported by its chassis cell engineering technology, that combine drug design and bioprocessing capabilities. It has production lines for finished dosage forms, including injectable solutions, lyophilized powder injections, and pre-filled syringes. The group has only one reportable operating segment, which is the research, development, and commercialisation of pharmaceutical products.
9GF Score

Get the complete analysis for HKSE:02659

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$15.94
Price